Варвара Лавренюк

At IQVIA, I developed growth and market-entry strategies for pharmaceutical clients across Central Asia and Southeast Asia. I recommended seven high-potential M&A targets, built a financial feasibility model for monoclonal antibody therapies, and designed launch strategy for a spinal muscular atrophy drug.

I also created a roadmap to regain market leadership across three therapeutic areas in Uzbekistan, including portfolio restructuring and reallocating 40% of expenditure toward high-growth products. My Excel-based KPI and ROI tool helped standardize tracking across three digital health projects.

Previously at Arthur Consulting, I identified a potential 15% sales increase for a petrochemical client and co-designed an investment optimization platform for a $10B railway portfolio that accelerated budget reallocation decisions by 20%.

I bring an Economics background, practical financial and econometric modeling skills, and experience turning market research, expert interviews, and data into actionable commercial decisions.